FDA.reportPublic FDA data

SENSORCAINE

Product NDC
63323-467
11-digit product format
633230467
Labeler code
63323
Product ID
63323-467_2b1a1f80-cb29-4ac1-9e72-20225ed45715
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
BUPIVACAINE HYDROCHLORIDE
Dosage form
INJECTION, SOLUTION
Route
PERINEURAL
Labeler
Fresenius Kabi USA, LLC
Application
NDA018304
Marketing category
NDA
Marketing start
2010-11-19
Substance
BUPIVACAINE HYDROCHLORIDE
Active strength
5 mg/mL
Pharmacologic classes
Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Orange Book products#

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N018304-001SENSORCAINEBUPIVACAINE HYDROCHLORIDE0.25%INJECTABLE / INJECTIONAPRLD, Approved before 1982
N018304-002SENSORCAINEBUPIVACAINE HYDROCHLORIDE0.5%INJECTABLE / INJECTIONAPRLD, Approved before 1982
N018304-003SENSORCAINEBUPIVACAINE HYDROCHLORIDE0.75%INJECTABLE / INJECTIONAPRLD, Approved before 1982
N018304-004SENSORCAINEBUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE0.5%;0.0091MG/MLINJECTABLE / INJECTIONAPRLD1983-09-02
N018304-005SENSORCAINEBUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE0.75%;0.0091MG/MLINJECTABLE / INJECTIONAPRLD1983-09-02

Therapeutic equivalence codes#

Application-product, TE code table
Application-productTE code
N018304-001AP
N018304-002AP
N018304-003AP
N018304-004AP
N018304-005AP

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
SENSORCAINE MPFBUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATEFresenius Kabi USA, LLCeb6d8fee-def4-4c96-9972-695e8cea8ea82024-10-15Boxed warning, Warnings, Adverse reactionsExact identifier

Boxed warning cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

boxed warning

THE 0.75% CONCENTRATION OF SENSORCAINE INJECTION IS NOT RECOMMENDED FOR OBSTETRICAL ANESTHESIA. THERE HAVE BEEN REPORTS OF CARDIAC ARREST WITH DIFFICULT RESUSCITATION OR DEATH DURING USE OF BUPIVACAINE FOR EPIDURAL ANESTHESIA IN OBSTETRICAL PATIENTS. IN MOST CASES, THIS HAS FOLLOWED USE OF THE 0.75% CONCENTRATION. RESUSCITATION HAS BEEN DIFFICULT OR IMPOSSIBLE DESPITE APPARENTLY ADEQUATE PREPARATION AND APPROPRIATE MANAGEMENT. CARDIAC ARREST HAS OCCURRED AFTER CONVULSIONS RESULTING FROM SYSTEMIC TOXICITY, PRESUMABLY FOLLOWING UNINTENTIONAL INTRAVASCULAR INJECTION. THE 0.75% CONCENTRATION SHOULD BE RESERVED FOR SURGICAL PROCEDURES WHERE A HIGH DEGREE OF MUSCLE RELAXATION AND PROLONGED EFFECT ARE NECESSARY. LOCAL ANESTHETICS SHOULD ONLY BE EMPLOYED BY CLINICIANS WHO ARE WELL VERSED IN DIAGNOSIS AND MANAGEMENT OF DOSE-RELATED TOXICITY AND OTHER ACUTE EMERGENCIES WHICH MIGHT ARISE FROM THE BLOCK TO BE EMPLOYED, AND THEN ONLY AFTER INSURING THE IMMEDIATE AVAILABILITY OF OXYGEN, OTHER RESUSCITATIVE DRUGS, CARDIOPULMONARY RESUSCITATIVE EQUIPMENT, AND THE PERSONNEL RESOURCES NEEDED FOR PROPER MANAGEMENT OF TOXIC REACTIONS AND RELATED EMERGENCIES (see also ADVERSE REACTIONS , PRECAUTIONS , and OVERDOSAGE ). DELAY IN PROPER MANAGEMENT OF DOSE-RELATED TOXICITY, UNDERVENTILATION FROM ANY CAUSE AND/OR ALTERED SENSITIVITY MAY LEAD TO THE DEVELOPMENT OF ACIDOSIS, CARDIAC ARREST AND, POSSIBLY, DEATH. Local anesthetic solutions containing antimicrobial preservatives, i.e., those supplied in multiple-dose vials, should not be used for epidural or caudal anesthesia because safety has not been established with regard to intrathecal injection, either intentionally or unintentionally, of such preservatives. Intra-articular infusions of local anesthetics following arthroscopic and other surgical procedures is an unapproved use, and there have been post-marketing reports of chondrolysis in patients receiving such infusions. The majority of reported cases of chondrolysis have involved the shoulder joint; cases of gleno-humeral chondrolysis have been described in pediatric and adult patients following intra-articular infusions of local anesthetics with and without epinephrine for periods of 48 to 72 hours. There is insufficient information to determine whether shorter infusion periods are not associated with these findings. The time of onset of symptoms, such as joint pain, stiffn...

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

warnings

WARNINGS THE 0.75% CONCENTRATION OF SENSORCAINE INJECTION IS NOT RECOMMENDED FOR OBSTETRICAL ANESTHESIA. THERE HAVE BEEN REPORTS OF CARDIAC ARREST WITH DIFFICULT RESUSCITATION OR DEATH DURING USE OF BUPIVACAINE FOR EPIDURAL ANESTHESIA IN OBSTETRICAL PATIENTS. IN MOST CASES, THIS HAS FOLLOWED USE OF THE 0.75% CONCENTRATION. RESUSCITATION HAS BEEN DIFFICULT OR IMPOSSIBLE DESPITE APPARENTLY ADEQUATE PREPARATION AND APPROPRIATE MANAGEMENT. CARDIAC ARREST HAS OCCURRED AFTER CONVULSIONS RESULTING FROM SYSTEMIC TOXICITY, PRESUMABLY FOLLOWING UNINTENTIONAL INTRAVASCULAR INJECTION. THE 0.75% CONCENTRATION SHOULD BE RESERVED FOR SURGICAL PROCEDURES WHERE A HIGH DEGREE OF MUSCLE RELAXATION AND PROLONGED EFFECT ARE NECESSARY. LOCAL ANESTHETICS SHOULD ONLY BE EMPLOYED BY CLINICIANS WHO ARE WELL VERSED IN DIAGNOSIS AND MANAGEMENT OF DOSE-RELATED TOXICITY AND OTHER ACUTE EMERGENCIES WHICH MIGHT ARISE FROM THE BLOCK TO BE EMPLOYED, AND THEN ONLY AFTER INSURING THE IMMEDIATE AVAILABILITY OF OXYGEN, OTHER RESUSCITATIVE DRUGS, CARDIOPULMONARY RESUSCITATIVE EQUIPMENT, AND THE PERSONNEL RESOURCES NEEDED FOR PROPER MANAGEMENT OF TOXIC REACTIONS AND RELATED EMERGENCIES (see also ADVERSE REACTIONS , PRECAUTIONS , and OVERDOSAGE ). DELAY IN PROPER MANAGEMENT OF DOSE-RELATED TOXICITY, UNDERVENTILATION FROM ANY CAUSE AND/OR ALTERED SENSITIVITY MAY LEAD TO THE DEVELOPMENT OF ACIDOSIS, CARDIAC ARREST AND, POSSIBLY, DEATH. Local anesthetic solutions containing antimicrobial preservatives, i.e., those supplied in multiple-dose vials, should not be used for epidural or caudal anesthesia because safety has not been established with regard to intrathecal injection, either intentionally or unintentionally, of such preservatives. Intra-articular infusions of local anesthetics following arthroscopic and other surgical procedures is an unapproved use, and there have been post-marketing reports of chondrolysis in patients receiving such infusions. The majority of reported cases of chondrolysis have involved the shoulder joint; cases of gleno-humeral chondrolysis have been described in pediatric and adult patients following intra-articular infusions of local anesthetics with and without epinephrine for periods of 48 to 72 hours. There is insufficient information to determine whether shorter infusion periods are not associated with these findings. The time of onset of symptoms, such as joint pai...

Adverse reactions cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

adverse reactions

ADVERSE REACTIONS Reactions to Sensorcaine (bupivacaine HCl) are characteristic of those associated with other amide- type local anesthetics. A major cause of adverse reactions to this group of drugs is excessive plasma levels, which may be due to overdosage, unintentional intravascular injection, or slow metabolic degradation. The most commonly encountered acute adverse experiences which demand immediate counter-measures are related to the central nervous system and the cardiovascular system. These adverse experiences are generally dose related and due to high plasma levels which may result from overdosage, rapid absorption from the injection site, diminished tolerance, or from unintentional intravascular injection of the local anesthetic solution. In addition to systemic dose-related toxicity, unintentional subarachnoid injection of drug during the intended performance of caudal or lumbar epidural block or nerve blocks near the vertebral column (especially in the head and neck region) may result in underventilation or apnea (“Total or High Spinal”). Also, hypotension due to loss of sympathetic tone and respiratory paralysis or underventilation due to cephalad extension of the motor level of anesthesia may occur. This may lead to secondary cardiac arrest if untreated. Patients over 65 years, particularly those with hypertension, may be at increased risk for experiencing the hypotensive effects of bupivacaine. Factors influencing plasma protein binding, such as acidosis, systemic diseases which alter protein production, or competition of other drugs for protein binding sites, may diminish individual tolerance. Central Nervous System Reactions These are characterized by excitation and/or depression. Restlessness, anxiety, dizziness, tinnitus, blurred vision, or tremors may occur, possibly proceeding to convulsions. However, excitement may be transient or absent, with depression being the first manifestation of an adverse reaction. This may quickly be followed by drowsiness merging into unconsciousness and respiratory arrest. Other central nervous system effects may be nausea, vomiting, chills, and constriction of the pupils. The incidence of convulsions associated with the use of local anesthetics varies with the procedure used and the total dose administered. In a survey of studies of epidural anesthesia, overt toxicity progressing to convulsions occurred...

Additional Listing Data#

Finished product
Yes
Brand name base
SENSORCAINE
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
BUPIVACAINE HYDROCHLORIDE5 mg/mL

Harmonized Identifiers#

Field, Values table
FieldValues
Unii7TQO7W3VT8, 30Q7KI53AK
Rxcui1012391, 1012396, 1012404, 1012421, 1012455, 1012457, 1672917, 1672919, 1673296, 1673298, 1724880, 1724881, 1724884, 1724885, 1725078, 1725082, 1725175, 1725177

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
0b4ec9ca-d305-43fc-88dd-7a510313efe0Product name120260105
bb209f42-a85f-4fee-9d3d-c9dded168625Product name120251208
49628fc7-2031-4c28-bd31-0ef3aa8f44a3Product name320251118
cbf85893-59ef-423f-87d4-a573c000a8b9Product name820250731
b5b1095b-40cd-8a9e-b111-502545045b07Product name420250325
e190029e-423b-473c-8e04-2ada59b5b711Product name120250314
5dad6767-dcd1-b0da-8727-7f3f7bc3a435Product name220250303
e0031c74-3853-42bc-8e10-86dbbe83992eProduct name220231116
362d7abb-94e6-4c60-9a58-266894157713Product name120231023
f7046b89-2016-499a-adc6-78479172abc6Product name120230425
6bd95106-a412-1dad-b9cc-4cb74bfb27ceProduct name220230315
e3a99641-4540-4894-9108-00cab3c57b7eProduct name120211207
f1e0dc7e-7d61-4625-b6d9-4894927679d7Product name220211025
5da98533-f072-406b-9e1b-6ac19eca9926Product name120210622
306b993e-3140-4823-ad5e-88b708f9d2acProduct name120210510
e4870509-7e28-6f92-f0be-dd3dd889a9cfProduct name520200810
a831e694-3663-4a83-82be-6c309429f750Product name220200608
6e9d4a47-c464-b93e-aebc-ad7bffc9c4cdProduct name220190619
444b3e50-f226-46ef-bfca-2e7035d140cdProduct name120190611
816b97af-edc5-4060-aff1-b814bdbcad50Product name120190415
2686d634-e712-4007-8dbf-3d37c6c4d71fProduct name120181121
7cda52fc-125f-421c-8fea-bc1974370c49Product name220180703
fa8b5901-e681-426f-82fe-54f6d81ec698Product name420180619
bd49bb86-2d32-4a7a-a594-eeda2e29af42Product name120180118
c08ab52f-2fc8-4409-9d9f-ed8edc0bd070Product name120171221
3becbe78-12d9-4ad2-9b4c-1e36f8d1303aProduct name120170815
419aab54-5d5a-4146-9453-026d4a9991beProduct name220170525
d5e51f11-ad28-caa4-4b49-4143974782adProduct name120150831
290f523a-f9db-9774-b5a9-e1f908ac1782Product name120150828
89dac932-b90a-4410-9ab1-84c53e57de25Product name120150316
5668b646-cd56-c3c7-bdea-3f6b1a8840dbProduct name120140508
684ea482-2e8b-14af-5664-b98f1e402036Product name120140508
810ab97e-f109-f41c-7c83-6a652a9cbf43Product name120140508
87711080-88eb-65c5-b2dd-bf99e700a372Product name120140508
8dbefedf-0a0d-a224-5a3c-66dc9e11c2ddProduct name120140508
b060cc1a-fe47-856b-0b77-4448b5963de8Product name120140508
c6b65c52-69c7-df49-550a-a50c137f6218Product name120140508
ec2149b3-5c6d-5344-f757-c86411073075Product name120140508
ed912195-5da0-0f2f-6f4b-3ef17710cbe3Product name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
63323-467-01SENSORCAINE50 mL in 1 VIAL, MULTI-DOSEINJECTION, SOLUTION5010
63323-467-57SENSORCAINE25 in 1 TRAYINJECTION, SOLUTION2510

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
63323-467-01ML - Milliliter63323-467088c5bdc-07a9-4f30-8e6b-1bfdfaa2550d12021-12-08
63323-467-57ML - Milliliter63323-46741dfd54e-4aab-423b-ad8b-f50dcb12791d12012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
BUPIVACAINE HYDROCHLORIDEACTIVE INGREDIENT7TQO7W3VT8SENSORCAINE (BUPIVACAINE HYDROCHLORIDE) INJECTION, SOLUTION SENSORCAINE MPF (BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC]6
EPINEPHRINE BITARTRATEACTIVE INGREDIENT30Q7KI53AKSENSORCAINE (BUPIVACAINE HYDROCHLORIDE) INJECTION, SOLUTION SENSORCAINE MPF (BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC]6
BUPIVACAINEACTIVE MOIETYY8335394ROSENSORCAINE (BUPIVACAINE HYDROCHLORIDE) INJECTION, SOLUTION SENSORCAINE MPF (BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC]6
EPINEPHRINEACTIVE MOIETYYKH834O4BHSENSORCAINE (BUPIVACAINE HYDROCHLORIDE) INJECTION, SOLUTION SENSORCAINE MPF (BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC]6
CITRIC ACID MONOHYDRATEINACTIVE INGREDIENT2968PHW8QPSENSORCAINE (BUPIVACAINE HYDROCHLORIDE) INJECTION, SOLUTION SENSORCAINE MPF (BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC]6
HYDROCHLORIC ACIDINACTIVE INGREDIENTQTT17582CBSENSORCAINE (BUPIVACAINE HYDROCHLORIDE) INJECTION, SOLUTION SENSORCAINE MPF (BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC]6
METHYLPARABENINACTIVE INGREDIENTA2I8C7HI9TSENSORCAINE (BUPIVACAINE HYDROCHLORIDE) INJECTION, SOLUTION SENSORCAINE MPF (BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC]6
SODIUM CHLORIDEINACTIVE INGREDIENT451W47IQ8XSENSORCAINE (BUPIVACAINE HYDROCHLORIDE) INJECTION, SOLUTION SENSORCAINE MPF (BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC]6
SODIUM HYDROXIDEINACTIVE INGREDIENT55X04QC32ISENSORCAINE (BUPIVACAINE HYDROCHLORIDE) INJECTION, SOLUTION SENSORCAINE MPF (BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC]6
SODIUM METABISULFITEINACTIVE INGREDIENT4VON5FNS3CSENSORCAINE (BUPIVACAINE HYDROCHLORIDE) INJECTION, SOLUTION SENSORCAINE MPF (BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC]6
Bupivacaine HydrochlorideACTIVE INGREDIENT7TQO7W3VT8SENSORCAINE (BUPIVACAINE HYDROCHLORIDE) INJECTION, SOLUTION [GENERAL INJECTABLES & VACCINES, INC]1
BupivacaineACTIVE MOIETYY8335394ROSENSORCAINE (BUPIVACAINE HYDROCHLORIDE) INJECTION, SOLUTION [GENERAL INJECTABLES & VACCINES, INC]1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
63323-467SENSORCAINE (BUPIVACAINE HYDROCHLORIDE) INJECTION, SOLUTION SENSORCAINE MPF (BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC]10Current NDC, Legacy NDC, 2 package rows20241031_eb6d8fee-def4-4c96-9972-695e8cea8ea8.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
1725078BUPivacaine HCl 0.25 % in 10 ML InjectionPSNeb6d8fee-def4-4c96-9972-695e8cea8ea810
1725082BUPivacaine HCl 0.25 % in 30 ML InjectionPSNeb6d8fee-def4-4c96-9972-695e8cea8ea810
1012396BUPivacaine HCl 0.25 % Injectable SolutionPSNeb6d8fee-def4-4c96-9972-695e8cea8ea810
1672917BUPivacaine HCl 0.5 % / EPINEPHrine 1:200,000 in 10 ML InjectionPSNeb6d8fee-def4-4c96-9972-695e8cea8ea810
1672919BUPivacaine HCl 0.5 % / EPINEPHrine 1:200,000 in 30 ML InjectionPSNeb6d8fee-def4-4c96-9972-695e8cea8ea810
1724880BUPivacaine HCl 0.5 % in 10 ML InjectionPSNeb6d8fee-def4-4c96-9972-695e8cea8ea810
1724884BUPivacaine HCl 0.5 % in 30 ML InjectionPSNeb6d8fee-def4-4c96-9972-695e8cea8ea810
1012404BUPivacaine HCl 0.5 % Injectable SolutionPSNeb6d8fee-def4-4c96-9972-695e8cea8ea810
1012391BUPivacaine HCl 0.75 % / EPINEPHrine 1:200,000 in 30 ML InjectionPSNeb6d8fee-def4-4c96-9972-695e8cea8ea810
1725175Sensorcaine 0.25 % in 10 ML InjectionPSNeb6d8fee-def4-4c96-9972-695e8cea8ea810
1725177Sensorcaine 0.25 % in 30 ML InjectionPSNeb6d8fee-def4-4c96-9972-695e8cea8ea810
1012455Sensorcaine 0.25 % Injectable SolutionPSNeb6d8fee-def4-4c96-9972-695e8cea8ea810
1673298Sensorcaine 0.5 % / EPINEPHrine 1:200,000 in 30 ML InjectionPSNeb6d8fee-def4-4c96-9972-695e8cea8ea810
1724881Sensorcaine 0.5 % in 10 ML InjectionPSNeb6d8fee-def4-4c96-9972-695e8cea8ea810
1724885Sensorcaine 0.5 % in 30 ML InjectionPSNeb6d8fee-def4-4c96-9972-695e8cea8ea810
1012457Sensorcaine 0.5 % Injectable SolutionPSNeb6d8fee-def4-4c96-9972-695e8cea8ea810
1012421Sensorcaine 0.75 % / EPINEPHrine 1:200,000 in 30 ML InjectionPSNeb6d8fee-def4-4c96-9972-695e8cea8ea810
1673296Sensorcaine 5 % / EPINEPHrine 1:200,000 in 10 ML InjectionPSNeb6d8fee-def4-4c96-9972-695e8cea8ea810
172517510 ML bupivacaine hydrochloride 2.5 MG/ML Injection [Sensorcaine]SBDeb6d8fee-def4-4c96-9972-695e8cea8ea810
167329610 ML bupivacaine hydrochloride 5 MG/ML / epinephrine 0.005 MG/ML Injection [Sensorcaine with Epinephrine]SBDeb6d8fee-def4-4c96-9972-695e8cea8ea810
172488110 ML bupivacaine hydrochloride 5 MG/ML Injection [Sensorcaine]SBDeb6d8fee-def4-4c96-9972-695e8cea8ea810
172517730 ML bupivacaine hydrochloride 2.5 MG/ML Injection [Sensorcaine]SBDeb6d8fee-def4-4c96-9972-695e8cea8ea810
167329830 ML bupivacaine hydrochloride 5 MG/ML / epinephrine 0.005 MG/ML Injection [Sensorcaine with Epinephrine]SBDeb6d8fee-def4-4c96-9972-695e8cea8ea810
172488530 ML bupivacaine hydrochloride 5 MG/ML Injection [Sensorcaine]SBDeb6d8fee-def4-4c96-9972-695e8cea8ea810
101242130 ML bupivacaine hydrochloride 7.5 MG/ML / epinephrine 0.005 MG/ML Injection [Sensorcaine with Epinephrine]SBDeb6d8fee-def4-4c96-9972-695e8cea8ea810
1012455bupivacaine hydrochloride 2.5 MG/ML Injectable Solution [Sensorcaine]SBDeb6d8fee-def4-4c96-9972-695e8cea8ea810
1012457bupivacaine hydrochloride 5 MG/ML Injectable Solution [Sensorcaine]SBDeb6d8fee-def4-4c96-9972-695e8cea8ea810
172507810 ML bupivacaine hydrochloride 2.5 MG/ML InjectionSCDeb6d8fee-def4-4c96-9972-695e8cea8ea810
167291710 ML bupivacaine hydrochloride 5 MG/ML / epinephrine 0.005 MG/ML InjectionSCDeb6d8fee-def4-4c96-9972-695e8cea8ea810
172488010 ML bupivacaine hydrochloride 5 MG/ML InjectionSCDeb6d8fee-def4-4c96-9972-695e8cea8ea810
172508230 ML bupivacaine hydrochloride 2.5 MG/ML InjectionSCDeb6d8fee-def4-4c96-9972-695e8cea8ea810
167291930 ML bupivacaine hydrochloride 5 MG/ML / epinephrine 0.005 MG/ML InjectionSCDeb6d8fee-def4-4c96-9972-695e8cea8ea810
172488430 ML bupivacaine hydrochloride 5 MG/ML InjectionSCDeb6d8fee-def4-4c96-9972-695e8cea8ea810
101239130 ML bupivacaine hydrochloride 7.5 MG/ML / epinephrine 0.005 MG/ML InjectionSCDeb6d8fee-def4-4c96-9972-695e8cea8ea810
1012396bupivacaine hydrochloride 2.5 MG/ML Injectable SolutionSCDeb6d8fee-def4-4c96-9972-695e8cea8ea810
1012404bupivacaine hydrochloride 5 MG/ML Injectable SolutionSCDeb6d8fee-def4-4c96-9972-695e8cea8ea810
172517510 ML Sensorcaine 2.5 MG/ML InjectionSYeb6d8fee-def4-4c96-9972-695e8cea8ea810
172488110 ML Sensorcaine 5 MG/ML InjectionSYeb6d8fee-def4-4c96-9972-695e8cea8ea810
172517730 ML Sensorcaine 2.5 MG/ML InjectionSYeb6d8fee-def4-4c96-9972-695e8cea8ea810
172488530 ML Sensorcaine 5 MG/ML InjectionSYeb6d8fee-def4-4c96-9972-695e8cea8ea810
1725078bupivacaine HCl 0.25 % in 10 ML InjectionSYeb6d8fee-def4-4c96-9972-695e8cea8ea810
1725082bupivacaine HCl 0.25 % per 30 ML InjectionSYeb6d8fee-def4-4c96-9972-695e8cea8ea810
1672917bupivacaine HCl 0.5 % / epinephrine (as bitartrate) 1:200,000 per 10 ML InjectionSYeb6d8fee-def4-4c96-9972-695e8cea8ea810
1672919bupivacaine HCl 0.5 % / epinephrine (as bitartrate) 1:200,000 per 30 ML InjectionSYeb6d8fee-def4-4c96-9972-695e8cea8ea810
1724880bupivacaine HCl 0.5 % in 10 ML InjectionSYeb6d8fee-def4-4c96-9972-695e8cea8ea810
1724884bupivacaine HCl 0.5 % in 30 ML InjectionSYeb6d8fee-def4-4c96-9972-695e8cea8ea810
1012391bupivacaine HCl 0.75 % / epinephrine (as epinephrine bitartrate) 1:200,000 per 30 ML InjectionSYeb6d8fee-def4-4c96-9972-695e8cea8ea810
1012396bupivacaine hydrochloride 0.25 % Injectable SolutionSYeb6d8fee-def4-4c96-9972-695e8cea8ea810
1012404bupivacaine hydrochloride 0.5 % Injectable SolutionSYeb6d8fee-def4-4c96-9972-695e8cea8ea810
1012455Sensorcaine 0.25 % Injectable SolutionSYeb6d8fee-def4-4c96-9972-695e8cea8ea810
1673298Sensorcaine 0.5 % / epinephrine (as bitratrate) 1:200,000 in 30 mL InjectionSYeb6d8fee-def4-4c96-9972-695e8cea8ea810
1012457Sensorcaine 0.5 % Injectable SolutionSYeb6d8fee-def4-4c96-9972-695e8cea8ea810
1012455Sensorcaine 2.5 MG/ML Injectable SolutionSYeb6d8fee-def4-4c96-9972-695e8cea8ea810
1673296Sensorcaine 5 % / EPINEPHrine 1:200,000 per 10 ML InjectionSYeb6d8fee-def4-4c96-9972-695e8cea8ea810
1012457Sensorcaine 5 MG/ML Injectable SolutionSYeb6d8fee-def4-4c96-9972-695e8cea8ea810
1012421Sensorcaine with Epinephrine 0.75 % / 1:200,000 (bupivacaine hydrochloride / epinephrine (as epinephrine bitartrate) ) per 30 ML InjectionSYeb6d8fee-def4-4c96-9972-695e8cea8ea810
1725175Sensorcaine-MPF 0.25 % in 10 ML InjectionSYeb6d8fee-def4-4c96-9972-695e8cea8ea810
1725177Sensorcaine-MPF 0.25 % in 30 ML InjectionSYeb6d8fee-def4-4c96-9972-695e8cea8ea810
1724881Sensorcaine-MPF 0.5 % in 10 ML InjectionSYeb6d8fee-def4-4c96-9972-695e8cea8ea810
1724885Sensorcaine-MPF 0.5 % in 30 ML InjectionSYeb6d8fee-def4-4c96-9972-695e8cea8ea810
1012421Sensorcaine-MPF 0.75 % / epinephrine 1:200,000 per 30 ML InjectionSYeb6d8fee-def4-4c96-9972-695e8cea8ea810
1012404BUPivacaine HCl 0.5 % Injectable SolutionPSN100201ad-6e4d-4e91-8b5c-621d0bf0dcc25
1012457Sensorcaine 0.5 % Injectable SolutionPSN100201ad-6e4d-4e91-8b5c-621d0bf0dcc25
1012457bupivacaine hydrochloride 5 MG/ML Injectable Solution [Sensorcaine]SBD100201ad-6e4d-4e91-8b5c-621d0bf0dcc25
1012404bupivacaine hydrochloride 5 MG/ML Injectable SolutionSCD100201ad-6e4d-4e91-8b5c-621d0bf0dcc25
1012404bupivacaine hydrochloride 0.5 % Injectable SolutionSY100201ad-6e4d-4e91-8b5c-621d0bf0dcc25
1012457Sensorcaine 0.5 % Injectable SolutionSY100201ad-6e4d-4e91-8b5c-621d0bf0dcc25
1012457Sensorcaine 5 MG/ML Injectable SolutionSY100201ad-6e4d-4e91-8b5c-621d0bf0dcc25
1012396BUPivacaine HCl 0.25 % Injectable SolutionPSNe391f807-7699-6d82-e053-2a95a90ab6414
1012404BUPivacaine HCl 0.5 % Injectable SolutionPSNe391f807-7699-6d82-e053-2a95a90ab6414
1012396bupivacaine hydrochloride 2.5 MG/ML Injectable SolutionSCDe391f807-7699-6d82-e053-2a95a90ab6414
1012404bupivacaine hydrochloride 5 MG/ML Injectable SolutionSCDe391f807-7699-6d82-e053-2a95a90ab6414
1012396bupivacaine hydrochloride 0.25 % Injectable SolutionSYe391f807-7699-6d82-e053-2a95a90ab6414
1012404bupivacaine hydrochloride 0.5 % Injectable SolutionSYe391f807-7699-6d82-e053-2a95a90ab6414

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
63323-467-016332304670150 mL in 1 VIAL, MULTI-DOSE50 mlHistorical
63323-467-576332304675725 VIAL, MULTI-DOSE in 1 TRAY (63323-467-57) / 50 mL in 1 VIAL, MULTI-DOSE (63323-467-01) 2010-11-190000-00-00NoNoCurrent